If you are having trouble reading this email, read the online version

Denied: FDA rejects CBD dietary supplement petitions – article Denying three citizen petitions requesting the agency engage in rulemaking to allow CBD to be marketed in dietary supplements, FDA said it needs a new regulatory pathway instead. "This is an astonishing dereliction of duty, especially compared to the agility and professionalism the agency showed it was capable of during the pandemic," said NPA President and CEO Dan Fabricant. Read more at New Hope Network.		Independent testing finds Amazon supplements subpar – article An internal testing program conducted by NOW Foods and third-party lab Eurofins found significant quality issues among lesser-known supplements brands sold on Amazon. Learn about the disturbing results and the potentially serious implications for the broader industry when the largest supplement retailer hawks shoddy products at “too-good-to-be-true prices.” Read more here.

How might a massive proposed FDA overhaul impact supplements? – article In the wake of the infant formula crisis, the agency recently announced a sweeping proposal to reorganize the human foods program but how it might impact dietary supplements remains to be seen, according to FDA Commissioner Robert Califf. Find out what issues industry stakeholders raised during a Jan. 3 meeting with Califf and Principal Deputy Commissioner Janet Woodcock. Read more here.		Putting the proof back in health claims–leveling the clinically supported efficacy playing field – article Dietary supplement “structure/function” claims have long been shrouded in regulatory uncertainty, limiting their utilization by companies hoping to validate and differentiate their products. Radical Science attempts to bridge the gap with clinical trials on supplements for greater confidence in product claims and efficacy. Read more here.

Grappling with climate change’s impact on botanical supply chain – article Get botanical industry experts’ views on rising prices and risks of shortages (including threats to one of the world’s favorite botanicals) as companies struggle for supply strategies while facing tempestuous forecast. And, learn about one supplier’s climate change risk-management information subscription service created to help brands get ahead of extreme weather. Read more at Natural Products Insider.		Yes, sales are up—understanding why can give your supplement business an edge – article Dig into the data behind rising sales—consumer motivations and habits, trends and generational differences—for the big picture you need to fuel your plans with Inside the Bottle’s Supplement consumers today: Attitudes and behavior toward supplements and health. In case you missed it, you can download the free report here.

$25M lawsuit filed against ‘Liver King’ – article Catch the ready-for-Netflix saga of a 45-year-old social media influencer, famous for shirtlessly promoting eating raw meat—or, for the squeamish, his own line of grass-fed ground organ Ancestral Supplements. The class action suit accuses Brian Johnson of orchestrating a “cult-like, extreme and implausible regimented lifestyle,” and lying about steroid use as he raked in over $1 million a year. Grab popcorn and read more here.		New FTC Guidelines, are they overkill or overdue? Analyzing the new FTC Health Products Compliance Guidelines – webinar Join SPINS Market Insights Director Scott Dicker, food and dietary supplement FDA regulatory attorney Martin Hahn, The Clean Label Project founder Jackie Bowen, and Radicle Science co-founders Dr. Jeff Chen and Pelin Thorogood as they explore the new FTC guidelines and what they could mean for the future of the supplement industry. Read more at SPINS.

Inside the Bottle unites companies from across the supplement supply chain to advocate for a transparent, collaborative supplement industry that supports consumer health empowerment. #InsidetheBottle

PAID CONTENT

Meet our Inside the Bottle partners

Produced by

By Informa Markets

This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy).
Informa PLC's registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.

If you do not wish to receive further information from us, please click here.
Alternatively, to contact our data services team to have your details or preferences updated please email imdatateam@informa.com.